Browse the latest stories and reports on MSF from various media outlets.

A half-hour documentary on MSF's Ebola center in Kailahun, Sierra Leone, as the Ebola epidemic grows further out of control. View external media.

More >

Esther Sterk describes efforts to contain the Ebola outbreak in West Africa. View external media.

More >

MSF is raising concerns about trade negotiations that could prevent India from manufacturing affordable, generic versions of newer AIDS medications.

More >

New WHO guidelines for HIV treatment are a major step forward, but they will be a challenge for countries such as South Africa to implement, according to MSF's Dr. Gilles van Cutsem. 

More >

A House subcommittee held a hearing on international trade disputes with India. Most of the event was devoted to U.S. drug company Pfizer's complaints about Indian policies that have fostered the country's billion-dollar generics industry.

More >

South Africa has made major progress in the fight against AIDS since 2001, when MSF was the only organization providing antiretroviral treatment in the country. "Adherence clubs" piloted by MSF now make treatment more accessible than ever.

More >

  A measles epidemic is endangering many children in the Democratic Republic of Congo. MSF is treating patients and administering hundreds of thousands of measles vaccinations.

More >

Access to medicines is a crucial issue in private talks over the Trans-Pacific Partnership, the largest trade deal in U.S. history.

More >

NPR reports on the Ebola outbreak in the Democratic Republic of Congo and the challenges that health care workers face in responding to it. MSF's Alfonso Verdu and Armand Sprecher are interviewed.

More >

Novartis AG goes to India's Supreme Court on Wednesday to seek patent protection for its blockbuster cancer drug Glivec in a case that could deliver far-reaching ramifications for multinational pharmaceutical companies operating in India.... Novartis's critics, including Médecins Sans Frontières [Doctors Without Borders], say that if the company prevails, it could set a legal precedent that allows pharmaceutical giants to patent a range of drugs in India that are now available from generic producers, including HIV medicines. That would demolish a thriving low-cost industry and lead to higher prices, not just in India, they say, but elsewhere in the developing world where India is a major exporter of drugs.

More >

Pages